{"name":"Invicro","slug":"invicro","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Lead Candidate","genericName":"Lead Candidate","slug":"lead-candidate","indication":"Other","status":"phase_1"},{"name":"Amyvid","genericName":"Amyvid","slug":"amyvid","indication":"Positron emission tomography","status":"marketed"}]}],"pipeline":[{"name":"Lead Candidate","genericName":"Lead Candidate","slug":"lead-candidate","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Amyvid","genericName":"Amyvid","slug":"amyvid","phase":"marketed","mechanism":"Amyloid beta A4 protein","indications":["Positron emission tomography"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNUUxlc28zb1FFUHl1RjFTQWpZcUllMVh0ajU1REh5bVZwQkRMeS1lN1BZUmxzaFdVbmZyQlRrVWdKaEhBY0Etd3JzTWc3dkhTa3dVZl9EUWI5OEhzc1dhVFU1d1VYTjlHbUpxcFlnN2JUTzY1QlJkY3BTaW9NQVdJa0tCdFNrLTNZY1EtMTBn?oc=5","date":"2024-10-01","type":"pipeline","source":"Contract Pharma","summary":"Calyx and Invicro Rebrand as Perceptive - Contract Pharma","headline":"Calyx and Invicro Rebrand as Perceptive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPOHJsVFl4MUtPYVlybkN2VkZvX3VPbXg1N00yckJTeEc5M2pucnFBSllhOHl5S3ZhSWZsYTFmcTJ2WHNqa0w1TEl3V1ZuQTBSMlF3LXUxYWFfT1NwZHh5OVVaSFJVVlJpRXNVM2xPckhGaXczV043OXc5a2RaSXo5OXVvMXlPVWZhU2J0TTl3eVFvRnp2ZVQwNnowT3FJdzhEUm5ZN1VyNmU2TDYtVW9DMy1JQzAxTlU4MG1NVHlCSXl0WHNQSEdoNXpwdUN0WFRiTFBoV3JsUEF4WVh5WFltZzlnc01xaVBJYTVQeFB6Unc4SmxRb2lINnZ6QktNdw?oc=5","date":"2024-09-30","type":"pipeline","source":"prnewswire.com","summary":"Introducing Perceptive: A New Name for the Global Leader in Discovery, eClinical, and Imaging Services and Solutions - prnewswire.com","headline":"Introducing Perceptive: A New Name for the Global Leader in Discovery, eClinical, and Imaging Services and Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOQlE2WV9EYTZ1WHNaWlIxSzNJcVpfZlVVdTVpMkN6bUtYZlNaRWNaM0RrQmFVUXlGMW5XMV9pcTltWmU4T1dJSU8wMXhTLXFiUTVJX1N3d3lDVWxfRWFDWldZSkswNWZBemcyaVgxVllZcHpabmJwYkVnZHdRMjVHLTk2bW91TUlZa05tVExlODJJV2FKTHh6U09GSzhRSkZPX3pCTEFUQnRyNnJSak8zTndlQmZlRkk?oc=5","date":"2024-03-18","type":"deal","source":"Fierce Pharma","summary":"BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic - Fierce Pharma","headline":"BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQODNpbWdSNjRZSUx4WkRRY1E5MVVPRU9NbnNhbmFlSVBPYVRGT012dnVCczV1NUNXdmhpOWh4N2kyRnNraS02LWdycUxhY1RrN1NYTFVwLXNUUFRFN1MwZXNhOGtlMEM5dGNPWVhKbUpkc0tsbmxvZVF3dEoycGE3ZkVBVEdvTjJfTDdRY1lYR3pSRWdQZngxTUp5N2RsVExfWF9IclMtR0txNzJ3RnU2Vmp1SzBFRExSd1hlZFJpQ19DRkJkelhMekZNbW8wc3NhQUhsNldoanZjbUNGNHZkZWpxc2JOTVI3MEo0bXdRZnpDRU42dWc?oc=5","date":"2024-03-07","type":"pipeline","source":"BioSpace","summary":"Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical research community - BioSpace","headline":"Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQZVpmSDh0Y3lvZFZFNDRvZnpGQjh4WEFEd2xacndRdngyMWZFY1pvS25WdHBib1JhSXFjQU1VbGM1YzdUaHRDTFNMYzdJTHNrNGtjLUxWZ0NlcUxYbVVsWkJtNzRxRUNpR3lGRl85ekNZTG5Kblo4cVNPV3VnZ3pWbzl3b1I3TzBxaVlqbTlUSENkSUxvVkliVFk4WlU2eE9Rc2hjVWd6OA?oc=5","date":"2024-03-07","type":"deal","source":"Investors in Healthcare","summary":"UK: Calyx to acquire Invicro from REALM IDx - Investors in Healthcare","headline":"UK: Calyx to acquire Invicro from REALM IDx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFA0QS1nZUdtRUs5Q0o2eTdOQnBmM0VvZmFDX2FXS0NsZ2lTOUNyWnd3UW5USHB0VzZ0Vkh0bFBHc2hib1BCOGtVdnNmWERTOE5LNDBzY0g2Q21TMFpvTG0tX3V1b2RZa25aZlpzVzZBbGc2Vkk?oc=5","date":"2022-06-14","type":"deal","source":"BioSpace","summary":"Telix and Invicro Advance AI Partnership - BioSpace","headline":"Telix and Invicro Advance AI Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE4zVWFtRURuUlhZYXhZOGhFa3JqQ2NYMXhaUks3UVE2UV9LQjczZXVmYkFrYjJCODYxTlZLTmx2eHh2SzF4NlFJWTNRNFY0cE10eGlFazFnYUptZWl2ZnpxNlpSRjY4YkZ2WTFwZQ?oc=5","date":"2022-06-14","type":"deal","source":"팜뉴스","summary":"Telix and Invicro Advance AI Partnership - 팜뉴스","headline":"Telix and Invicro Advance AI Partnership - 팜뉴스","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOa29kako3RzZNZDlQRmR5NGV5RDNacHFzNWEySU1uUVg5TVhlSzNURFdFLVBMNFRJVXR1ZVBid3ZCcUpQaVpFU2t4aDRVajNiazI1NThUOHBwZEdvbFQ4SDhaTW9DdndMYzRleFpRTGdYMW5vYm1lLUxOWmNRVFpNWHhnYVlZOEVhTDcwcnVqT1R0RlVWNnc?oc=5","date":"2021-03-15","type":"pipeline","source":"Konica Minolta","summary":"Business Strategy 3: Growth Strategies for the Bio-Healthcare Business -Integrated Report (Annual Report) 2018 - Konica Minolta","headline":"Business Strategy 3: Growth Strategies for the Bio-Healthcare Business -Integrated Report (Annual Report) 2018","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOdlQ0UE5GWW5OZ09kMVFOa1l1U0R3Q0FSZWtYNU9sX2liNXpRQ0xwazZoY3NRSkw4X3UzRS1TNVZXd1l1WTZEWm9xa0NDOHNNb1l5cTcweXpvaXZOZG5iYzZQU2dWazBtTDBmOFhOY3p3dU1IR0d4YzN5WllXaTRIcjJ4ajViQWdCX1dtdW0zUnU0U2hpb3FuWG5UY0dBLXlwbGlfMC13M09PWnQ2YjV4ZlR5WDEyX2I4NHVwWnp0MGlkX1J0eFk0bFBXdG0taXBNeDZsYThYTXVLenpHX1FLTGxuRUZFZjg4X2FWdVBEc2lmeDZyaVk4d3hMQjdZMnBfcEY2MHk0amZ3NFY5SGlOVG45VkxLREow?oc=5","date":"2019-12-24","type":"pipeline","source":"Business Wire India","summary":"Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine - Business Wire India","headline":"Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPdDV2dEh2eGtmSEFEdFZlNjdkaXp4VUFmWDhzb0R4dXlMODU0R0FJMC1wN2t5R0xKUldwMlIzUGhESlpvMTZOWDJ0RkM1azd0Z3FIcVItaF9JdlRMY2tXaThRM1o3REs3MXF3TGlsRmJHSTFqQkJ5S1NQQWZOQTZIUUlRamgteENtN0lFN2Q0QUF2Q014a05WQlAzTTNuNmlYcmVQWWVKOTM2ZUR1S1R6R0ZJWHhqTThpOEQ0UWVMamRISEZRcUMtclRqRjN0bmNLUS1aZ0NwMTM2MV9leTlPSFVBdFdILUpFVTgxWEJWYzNETjd6eUpyMk51MlBxWGdrTTBWM3pJQ3c?oc=5","date":"2019-04-30","type":"deal","source":"BioSpace","summary":"Invicro and iThera Medical Announce a Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform - BioSpace","headline":"Invicro and iThera Medical Announce a Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT inVisi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQWFNRVlVrbWJoc0lGYW5xR0RZRXdRZElINzhCYzc0ZHlXTFM1N3g2THRURkQzM2oxbWdFdVJOakVPVW1XSDFsNzlWOVZsaVNPVk5qWTZ3QVJoSTI4UXZsOWdOMUtMQnhDWXBwRjJKd1VFa1JEdEZmbTZZU204UU51eUU3RC15a0ZfeGZENmExTnB3NEplQ0FmcEJVNkpBVWFDajB0RTdB?oc=5","date":"2018-08-24","type":"deal","source":"drugdiscoverytrends.com","summary":"Enigma Biomedical Group and Invicro Sign a Collaboration Agreement - drugdiscoverytrends.com","headline":"Enigma Biomedical Group and Invicro Sign a Collaboration Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPSTFVdExOTkhEbXpZUzJZeWxXUjZwMmpfX212OTB6c0xwRHFQUHEtUk9LMWZjZi0wMnM2NGR0ci0td3VHYXVXVlV4aU5RdW1waE1FYm1yTUVoQ2xTRU9FakNfVFAzal96NGIzNmkzZ1Uyd0Y3LUFSbWtNUUJRRWIxMWd1RXBwZ3psb2hidGpBcWk5Q2p0c2o4ZUpLY2FlWTVWR0dGMHBYeGF2S2cyMUx5eFpCdGZKOUJaUkE?oc=5","date":"2014-02-26","type":"deal","source":"Contract Pharma","summary":"Cyclotron Arrival at Translational Imaging Center Announced by CRO Partnership - Contract Pharma","headline":"Cyclotron Arrival at Translational Imaging Center Announced by CRO Partnership","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}